OTCMKTS:PPCB

Propanc Biopharma Stock Insider Trading

etoro logo Buy PPCB
*Your capital is at risk
$1.02
-0.0300 (-2.86%)
At Close: Aug 04, 2026

Propanc Biopharma Stock Insider Power

Based on the 48 latest insides trades, we have calculated the insider power to be negative at 0. In total, the insiders bought 560.62M and sold 661K PPCB shares in the last 48 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power

(Last 48 transactions)
0
Buy 560.62M shares
Sell 661K shares
79% Buy Activity
Negligible or No Correlation

No Significant Signals

No statistically significant buy or sell signals detected in recent insider data.

Historical Insider Trades

Date Type Person Role Amount
Feb 04, 2015
Buy
Common Stock, par value $0.001
J-Other
Nathanielsz James Andrew
CEO, CFO, Secretary, Treasurer
CEO / President 33 259 350
Value: $1,106.2B
Feb 04, 2015
Buy
Common Stock, par value $0.001
J-Other
Nathanielsz James Andrew
CEO, CFO, Secretary, Treasurer
CEO / President 33 259 350
Value: $1,106.2B
Feb 04, 2015
Buy
Common Stock, par value $0.001
J-Other
Kenyon Julian Norman
Director
Director 17 654 470
Value: $311.7B
Nov 09, 2014
Buy
Series A Preferred Stock
A-Award
Nathanielsz James Andrew
Chief Executive Officer
CEO / President 500 000
Value: $0
Nov 09, 2014
Buy
Series A Preferred Stock
A-Award
Nathanielsz James Andrew
Chief Executive Officer
CEO / President 500 000
Value: $0
Jul 05, 2013
Sell
Common stock, par value $0.001 per share
S-Sale
Nathanielsz James Andrew
Chief Executive Officer
CEO / President 55 000
Value: $5K
Jul 05, 2013
Sell
Common stock, par value $0.001 per share
S-Sale
Nathanielsz James Andrew
Chief Executive Officer
CEO / President 55 000
Value: $5K
Jan 23, 2013
Sell
Common stock, par value $0.001 per share
S-Sale
Nathanielsz James Andrew
Chief Executive Officer
CEO / President 15 000
Value: $3K
Jan 23, 2013
Sell
Common stock, par value $0.001 per share
S-Sale
Nathanielsz James Andrew
Chief Executive Officer
CEO / President 15 000
Value: $3K
Dec 13, 2012
Sell
Common stock, par value $0.001 per share
S-Sale
Nathanielsz James Andrew
Chief Executive Officer
CEO / President 5 500
Value: $1K
Dec 13, 2012
Sell
Common stock, par value $0.001 per share
S-Sale
Nathanielsz James Andrew
Chief Executive Officer
CEO / President 5 500
Value: $1K
Sep 14, 2012
Sell
Common stock, par value $0.001 per share
S-Sale
Nathanielsz James Andrew
Chief Executive Officer
CEO / President 5 000
Value: $1K
Sep 14, 2012
Sell
Common stock, par value $0.001 per share
S-Sale
Nathanielsz James Andrew
Chief Executive Officer
CEO / President 5 000
Value: $1K
Sep 04, 2012
Sell
Common stock, par value $0.001 per share
S-Sale
Nathanielsz James Andrew
Chief Executive Officer
CEO / President 250 000
Value: $50.0K
Sep 04, 2012
Sell
Common stock, par value $0.001 per share
S-Sale
Nathanielsz James Andrew
Chief Executive Officer
CEO / President 250 000
Value: $50.0K
Aug 23, 2012
Buy
Common Stock
P-Purchase
Nathanielsz James Andrew
Chief Executive Officer
CEO / President 250 000
Value: $50.0K
Aug 23, 2012
Buy
Common Stock
P-Purchase
Nathanielsz James Andrew
Chief Executive Officer
CEO / President 250 000
Value: $50.0K
Jul 16, 2012
Buy
Shares in Propanc Health Group Corp.
Kenyon Julian Norman
Director 0
Value: $0
Jul 16, 2012
Buy
Shares in Propanc Health Group Corp.
Kenyon Julian Norman
Director 0
Value: $0
Jul 16, 2012
Buy
Shares in Propanc Health Group Corp.
Kenyon Julian Norman
Director 0
Value: $0
Jul 16, 2012
Buy
Shares in Propanc Health Group Corp.
Kenyon Julian Norman
Director 0
Value: $0
Dec 16, 2011
Buy
Common Stock
Nathanielsz James Andrew
Chief Executive Officer
CEO / President 0
Value: $0
Dec 16, 2011
Buy
Common Stock
Nathanielsz James Andrew
Chief Executive Officer
CEO / President 0
Value: $0

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

Click to get the best stock tips daily for free!
ABOUT PROPANC BIOPHARMA INC
Propanc Biopharma
Propanc Biopharma, Inc., a biopharmaceutical company, focuses on the development of cancer treatments for patients with pancreatic, ovarian, and colorectal cancer in Australia. Its lead product is PRP, a formulation that is in preclinical phase of development designed to enhance the anti-cancer effects of multiple enzymes acting synergistically. The company has a research collaboration with University of Jaén to commence the POP1 joint drug disc...
GOLDEN STAR
Ticker Change Signal Date
FCX
$62.63
7.46% Jul 31
MC
$67.08
2.40% Jul 31
ARW
$212.85
6.96% Jul 30
BIIB
$202.19
3.10% Jul 24
F
FERG
$230.67
10.77% Jul 24

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE